Rentschler Biotechnologie GmbH, a contract manufacturing organization for the development and production of biopharmaceuticals, is expanding its manufacturing capacity. The company is adding a 2,000-L single-use bioreactor to its facility in Laupheim, Germany. The expansion is anticipated to be fully operational by the end of the first quarter of 2015.

The new 2,000-L single-use bioreactor will supplement two existing 1,000-L single-use bioreactors already in operation and will double the company’s total single-use production capacity. Rentschler's manufacturing facility includes bioreactors up to 3,000 L and aseptic filling lines for vials (including lyophilization) and prefilled syringes.

“We see an increasing need for production capacity in the mid-scale. The expansion will allow us to match the growing demands of our clients for all clinical phases. The addition of the 2,000-L single-use bioreactor will increase our flexibility to serve the market with either stainless steel or single-use technology as the client requires,” said Frank Ternes, chief business officer at Rentschler, in a company release.  

Source: Rentschler Biotechnologie